[go: up one dir, main page]

NO974630D0 - Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon - Google Patents

Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon

Info

Publication number
NO974630D0
NO974630D0 NO974630A NO974630A NO974630D0 NO 974630 D0 NO974630 D0 NO 974630D0 NO 974630 A NO974630 A NO 974630A NO 974630 A NO974630 A NO 974630A NO 974630 D0 NO974630 D0 NO 974630D0
Authority
NO
Norway
Prior art keywords
hormone
preparation
pct
active ingredient
days
Prior art date
Application number
NO974630A
Other languages
English (en)
Other versions
NO974630L (no
NO313269B1 (no
Inventor
Juergen Spona
Bernd Duesterberg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7759440&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974630(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974630D0 publication Critical patent/NO974630D0/no
Publication of NO974630L publication Critical patent/NO974630L/no
Publication of NO313269B1 publication Critical patent/NO313269B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19974630A 1995-04-08 1997-10-07 Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon NO313269B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19513662A DE19513662A1 (de) 1995-04-08 1995-04-08 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1996/001529 WO1996032114A1 (de) 1995-04-08 1996-04-04 Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption

Publications (3)

Publication Number Publication Date
NO974630D0 true NO974630D0 (no) 1997-10-07
NO974630L NO974630L (no) 1997-12-05
NO313269B1 NO313269B1 (no) 2002-09-09

Family

ID=7759440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974630A NO313269B1 (no) 1995-04-08 1997-10-07 Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon

Country Status (16)

Country Link
US (1) US5980940A (no)
EP (1) EP0871453B1 (no)
JP (1) JPH11503440A (no)
KR (1) KR19980703702A (no)
CN (1) CN1077430C (no)
AT (1) ATE240735T1 (no)
AU (1) AU713771B2 (no)
CA (1) CA2217564A1 (no)
DE (2) DE19513662A1 (no)
DK (1) DK0871453T3 (no)
ES (1) ES2200062T3 (no)
NO (1) NO313269B1 (no)
NZ (1) NZ307178A (no)
PT (1) PT871453E (no)
RU (1) RU2165259C2 (no)
WO (1) WO1996032114A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
AU769482B2 (en) * 1999-09-23 2004-01-29 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
AU2002348272B2 (en) * 2001-12-05 2008-07-31 Theramex HQ UK Limited Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
NZ538342A (en) * 2002-08-28 2007-08-31 Robert Casper Estrogen replacement regimen
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
JP2007507534A (ja) * 2003-10-01 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 持続的三相避妊方法
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
EP2343979B1 (en) 2008-10-08 2020-04-08 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (en) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
WO2010111488A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
US20150206152A1 (en) * 2012-07-31 2015-07-23 New York University Anti-counterfeiting technique via attributes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (no) * 1966-11-02 1968-05-03
AU4168068A (en) * 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
GB8413070D0 (en) * 1984-05-22 1984-06-27 Mortimer C H Treatment of hair loss
FR2589735A1 (fr) * 1985-11-07 1987-05-15 Beillon Xavier Compositions anticonceptionnelles contenant un oestrogene et un progestatif
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4104385C1 (no) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
AU7843094A (en) * 1993-09-23 1995-04-10 Ortho Pharmaceutical Corporation Methods for the reduction of postmenopausal ldl cholesterol
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
RU2091019C1 (ru) * 1996-01-15 1997-09-27 Валентина Александровна Андрюшина Контрацептивное средство для животных и способ его получения

Also Published As

Publication number Publication date
CN1077430C (zh) 2002-01-09
CA2217564A1 (en) 1996-10-17
ATE240735T1 (de) 2003-06-15
EP0871453A1 (de) 1998-10-21
NO974630L (no) 1997-12-05
DK0871453T3 (da) 2003-09-15
WO1996032114A1 (de) 1996-10-17
DE59610462D1 (de) 2003-06-26
RU2165259C2 (ru) 2001-04-20
PT871453E (pt) 2003-10-31
CN1181011A (zh) 1998-05-06
AU713771B2 (en) 1999-12-09
ES2200062T3 (es) 2004-03-01
KR19980703702A (ko) 1998-12-05
NO313269B1 (no) 2002-09-09
JPH11503440A (ja) 1999-03-26
NZ307178A (en) 2000-01-28
EP0871453B1 (de) 2003-05-21
US5980940A (en) 1999-11-09
DE19513662A1 (de) 1996-10-10
AU5646296A (en) 1996-10-30

Similar Documents

Publication Publication Date Title
DK0750501T3 (da) Farmaceutisk kombinationspræparat til hormonal kontraception
NO976067D0 (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
NO974630L (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
KR20130022425A (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
CA2241192A1 (en) Contraceptive process and kit for female mammals that consists of a combination of gestagen and estrogen
Percival-Smith et al. Postcoital contraception with dl-norgestrel/ethinyl estradiol combination: six years experience in a student medical clinic
Van Santen et al. Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
FI971742A7 (fi) Kompetitiivisia progesteroniantagonisteja tarpeen sanelemaan raskauden ehkäisyyn naisilla
JP4908399B2 (ja) 天然エストロゲンに基づく段階型避妊製剤

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees